• Korean Journal of Psychosomatic Medicine
• /
• v.19 no.2
• /
• pp.92-100
• /
• 2011

Objectives：We developed a Korean version of the Brief Measure of Worry Severity(BMWS), and examined its reliability, validity, and factor structures. We also explored the associations of pathological worry with depression and anxiety. Methods：Three hundreds fifty-two subjects including community population and college students completed the BMWS, and 27 subjects repeated the scale three weeks later. Reliability was assessed by Cronbach's coefficient ${\alpha}$ and test-retest correlation. The external validity was examined by the correlation of the BMWS score with the scores of Beck Depression Inventory(BDI), Patient Health questionnaire-2(PHQ-2), State Anxiety Inven-tory(SAI), and Trait Anxiety Inventory(TAI). And principal component analysis was performed to evaluate the construct validity. The associations of pathological worry with depression and anxiety were explored using partial correlation analysis. Results：Cronbach's coefficient ${\alpha}$ for the BMWS was 0.904 and test-retest correlation was 0.56(P<0.01). The Spearman correlation coefficients of the BMWS score with the scores of BDI, PHQ-2, SAI, and TAI were 0.60(P<0.01), 0.42(P<0.01), 0.36(P<0.01), and 0.59(P<0.01), respectively. The BMWS showed unifactorial construct. When controlling for TAI score, the correlation coefficient between the BMWS score and the BDI score was 0.357(P<0.01), and when controlling for BDI score the correlation coefficient between the BMWS score and the TAI score was 0.446(P<0.01). Conclusion：The Korean version of the BMWS was found to be a reliable and valid questionnaire for measuring pathological worry. And we could identify the associations of the pathological worry with depression as well as anxiety.

• Anxiety and mood
• /
• v.11 no.1
• /
• pp.47-53
• /
• 2015

Objective : Generalized anxiety disorder (GAD) is a common anxiety disorder characterized by excessive worries and anxiety symptoms. To distinguish between pathological and normal worries, this study compared the contents and severity of worries among patients with GAD with those of matched non-psychiatric control Methods : Thirty outpatients with GAD receiving treatment at the psychiatric department of Hanyang University Guri Hospital were recruited. As a matched control group, we selected 30 adults without psychiatric history who participated in the Anxiety Disorder Survey, during the Mental Health Exposition held in Seoul in April, 2014. Matched demographic data were age, sex, education, and household income. Self-questionnaires included demographic data, contents of worry (10 categories of worries and each severity), and the Pennsylvania State Worry Questionnaire (PSWQ). Results : There was no statistical difference in the contents of worry between patient and control groups. However, the total PSWQ scores significantly higher in the GAD group. Conclusion : Our findings suggest that patients and non-patients worry about the similar contents and worries in GAD cannot be differentiated by what people worry about. Only the severity of worry was a distinguishable feature. Our finding supported inclusion of the diagnostic criterion of "excesslve wornes" in GAD.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• v.6 no.1
• /
• pp.116-122
• /
• 1995

목적 : 다음과 같은 fluoxetine으로 유발된 조증 증례를 보고한다. 이와 함께 fluoxetine사용이후 보고된 조증 증례보고를 모아서 정리하고 함께 문헌고찰을 하였다. 증례요약 : 가족력상 기분장애의 병력이 없었으며, 다른 주요 정신과적 질환의 병력은 없었다. 환아는 개인력상 5세경에 주의력 결핍, 과잉행동의 양상을 보였던 병력이 있었고, 13세때에 피해 망상, 환청이 지속되어 haloperidol로 치료받기 시작하였다. 이후 피해 망상의 내용을 언급하거나 환청에 영향받는 행동은 없어졌고 간혹 우울감을 호소하였다. 이후 정신분열증의 진단 하에 haloperidol만으로 3년간 유지하였다. 1994년 환아는 18세때 고3이 되면서 대입에 대한 걱정과 신체적인 허약감을 자주 호소하며, 우울증상이 두드려져 fluoxetine 20mg를 3일간 투여하던 중 갑자기 조증의 임상적 양상을 보이기 시작하여 본원의 입원치료를 받게 되었는데, 입원당시 보인 임상양상은 앙양된 기분, 이자극성(irritability), 사고의 비약, 연상의 이완과 지리멸렬, 과대망상, 피해망상, 관계망상, 환청 등이었고 사람, 장소, 시간에 대한 지남력까지 일시적으로 상실되는 심헌 정신병적 조증상태였다. 토의 : fluoxetine 사용이후 현재까지 세계적으로 문헌상 보고된 14개의 증례보고를 모아서 정리하였다. fluoxetine-induced mania의 병태생리학적인 기전은 명확하지 않지만 가능한 기전에 대해 토론하였다. 이 약물의 중대한 부작용중의 하나인 조증을 예방하기 위해, 이 약물을 다루는 의사는 가능한 조증 발병의 위험인자들에 대하여 인식하고, 약물의 용량조절시에도 주의를 하여야 한다. 가능한 발병 위험인자들에 관해서도 검토하였다.